These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 6973248
1. [Sjogren's syndrome and Sjogren's disease in rheumatology]. Nasonova V, Vasiljev V. Z Gesamte Inn Med; 1981 Mar 15; 36(6):199-203. PubMed ID: 6973248 [No Abstract] [Full Text] [Related]
2. Evaluation of the immune status in patients with primary and secondary Sjögren's syndrome. Slezák R, Krejsek J, Kopecký O, Drízhal I. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995 Mar 15; 38(1):11-2. PubMed ID: 7569721 [Abstract] [Full Text] [Related]
3. [Variants in the course of Sjögren's disease]. Vasil'ev VI, Kadagidze ZG, Simonova MV, Veskova TK, Iudina IuV. Ter Arkh; 1982 Mar 15; 54(6):41-9. PubMed ID: 6981223 [No Abstract] [Full Text] [Related]
5. Clinical and immunologic analysis of 25 Sjögren's syndrome cases. Ge MZ, Qi WN, Zhang Y. Chin Med J (Engl); 1981 Jun 15; 94(6):365-8. PubMed ID: 6788477 [No Abstract] [Full Text] [Related]
6. Immunologic diseases of the salivary glands. Deegan MJ. Otolaryngol Clin North Am; 1977 Jun 15; 10(2):351-61. PubMed ID: 302432 [No Abstract] [Full Text] [Related]
7. [T and B cells and ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease]. Arimori S, Ichikawa Y, Takaya M. Nihon Rinsho; 1983 Jun 15; 41(2):446-9. PubMed ID: 6602896 [No Abstract] [Full Text] [Related]
8. [Clinical study on nine male cases with Sjögren's syndrome (author's transl)]. Hara Y, Miyasaka N, Nishido T, Okuda M. Ryumachi; 1979 Oct 15; 19(5):410-5. PubMed ID: 524209 [No Abstract] [Full Text] [Related]
9. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans. Shen L, Suresh L, Li H, Zhang C, Kumar V, Pankewycz O, Ambrus JL. Clin Immunol; 2009 Mar 15; 130(3):304-12. PubMed ID: 19038581 [Abstract] [Full Text] [Related]
11. [The diagnostic value of the so-called Sjögren cells]. Urbaszek W, Aschermann I, Tautenhahn B, Perlick E. Z Gesamte Inn Med; 1970 Sep 01; 25(17):795-803. PubMed ID: 4097886 [No Abstract] [Full Text] [Related]
12. Reflections in the assessment of secondary Sjogren's syndrome. Hernández-Molina G, Avila-Casado C, Sánchez-Guerrero J. Rheumatology (Oxford); 2011 Aug 01; 50(8):1519-21. PubMed ID: 21672968 [No Abstract] [Full Text] [Related]
14. Interview with Joaquim Coll. What is going to happen tomorrow as far as secondary Sjögren's syndrome is concerned?. Interview by P. Youinou. Coll J. Ann Med Interne (Paris); 1993 Jan 31; 144(4):257-9. PubMed ID: 8368718 [No Abstract] [Full Text] [Related]
15. [Etiopathogenic aspects of Sjögren's syndrome]. Palomino Nicas J, Villar Ortiz J, Viciana Fernández P, Piedra Priego J, Carneado de la Fuente J. Rev Clin Esp; 1993 Jan 31; 173(5-6):253-8. PubMed ID: 6387825 [No Abstract] [Full Text] [Related]
17. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus. Hoffman RW. Arthritis Rheum; 2007 Oct 31; 56(10):3180-2. PubMed ID: 17907162 [No Abstract] [Full Text] [Related]
18. Primary Sjögren's syndrome at a glance today. Youinou P, Pers JO. Joint Bone Spine; 2015 Mar 31; 82(2):75-6. PubMed ID: 25619154 [No Abstract] [Full Text] [Related]
19. Decay-accelerating factor (DAF, CD55)-negative T lymphocytes in the peripheral blood of Sjögren's syndrome patients. Ichikawa Y, Masumoto A, Yoshida M, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Takaya M. Tokai J Exp Clin Med; 1996 Oct 31; 21(3):121-8. PubMed ID: 9239815 [Abstract] [Full Text] [Related]
20. [The regional circulation of the parotid gland in Sjögren's disease]. Varshavskiĭ AI, Guberskaia TA, Panchenko KI. Ter Arkh; 1990 Oct 31; 62(5):71-5. PubMed ID: 2396222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]